日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The CD94/NKG2A-HLA-E Axis as a Target in Cancer Immunotherapy: A Critical Perspective

CD94/NKG2A-HLA-E轴作为癌症免疫治疗的靶点:批判性视角

López-Botet, Miguel; Vilches, Carlos; Muntasell, Aura

Comparative two-dimensional NKG2A/CD94 cell membrane chromatography for targeted screening immune checkpoint inhibitors

比较二维NKG2A/CD94细胞膜色谱法用于靶向筛选免疫检查点抑制剂

Li, Yanting; Gu, Yanqiu; Zhang, Weiyue; Li, Tianhua; Chen, Chun; Wang, Chengliang; Chai, Yifeng; Ma, Xueqin; Chen, Xiaofei

Single cell profiling of circulating autoreactive CD4 T cells from patients with autoimmune liver diseases suggests tissue imprinting

自身免疫性肝病患者循环自身反应性 CD4 T 细胞的单细胞分析表明存在组织印迹

Anaïs Cardon #, Thomas Guinebretière #, Chuang Dong, Laurine Gil, Sakina Ado, Pierre-Jean Gavlovsky, Martin Braud, Richard Danger, Christoph Schultheiß, Aurélie Doméné, Perrine Paul-Gilloteaux, Caroline Chevalier, Laura Bernier, Jean-Paul Judor, Cynthia Fourgeux, Astrid Imbert, Marion Khaldi, Edouar

CD94-driven in vitro expansion of highly functional adaptive NKG2C(+) NKG2A(-) CD57(+) NK cells from CMV(+) healthy donors

CD94驱动的体外扩增来自CMV(+)健康供体的高功能适应性NKG2C(+)NKG2A(-)CD57(+)NK细胞

Giordano, Chiara; Carlomagno, Simona; Falco, Michela; Cantoni, Claudia; Vitale, Massimo; Caruana, Ignazio; Dirks, Johannes; Serio, Alberto; Muccio, Letizia; Bartalucci, Giulia; Bo, Alessandra; Locatelli, Franco; Bottino, Cristina; Sivori, Simona; Della Chiesa, Mariella

HLA-E/peptide complexes differentially interact with NKG2A/CD94 and T cell receptors

HLA-E/肽复合物与NKG2A/CD94和T细胞受体的相互作用存在差异。

Voogd, Linda; van den Broek, Remco L; van Wolfswinkel, Marjolein; Franken, Kees L M C; Ruibal, Paula; Jespers, Willem; Leitner, Judith; Steinberger, Peter; van Westen, Gerard J P; Ottenhoff, Tom H M; Joosten, Simone A

KLRD1 (CD94): A Prognostic Biomarker and Therapeutic Candidate in Head and Neck Squamous Cell Carcinoma

KLRD1 (CD94):头颈部鳞状细胞癌的预后生物标志物和治疗候选药物

Dong, Chengyuan; Lin, Ziyou; Hu, Yunzhao; Lu, Qun

CD94 as a novel marker for immunophenotyping of leukemia and lymphoma in dogs

CD94作为一种新型标志物用于犬白血病和淋巴瘤的免疫表型分析。

Blockeel, Anna; Demeyere, Kristel; Steenbrugge, Jonas; Paepe, Dominique; Krupa, Adriana; Martini, Valeria; Devriendt, Bert; Meyer, Evelyne

LAG-3 sustains TOX expression and regulates the CD94/NKG2-Qa-1b axis to govern exhausted CD8 T cell NK receptor expression and cytotoxicity

LAG-3 维持 TOX 表达并调节 CD94/NKG2-Qa-1b 轴,从而控制耗竭 CD8 T 细胞 NK 受体的表达和细胞毒性。

Shin Foong Ngiow ,Sasikanth Manne ,Yinghui Jane Huang ,Tarek Azar ,Zeyu Chen ,Divij Mathew ,Qingzhou Chen ,Omar Khan ,Jennifer E Wu ,Victor Alcalde ,Ahron J Flowers ,Sean McClain ,Amy E Baxter ,Makoto Kurachi ,Junwei Shi ,Alexander C Huang ,Josephine R Giles ,Arlene H Sharpe ,Dario A A Vignali ,E John Wherry

CD94+ natural killer cells potentiate pulmonary ischaemia-reperfusion injury

CD94+自然杀伤细胞加剧肺缺血再灌注损伤

Tasha Tsao ,Longhui Qiu ,Reena Bharti ,Avishai Shemesh ,Alberto M Hernandez ,Simon J Cleary ,Nancy Y Greenland ,Jesse Santos ,Ruoshi Shi ,Lu Bai ,Jennifer Richardson ,Kimberley Dilley ,Matthias Will ,Nenad Tomasevic ,Tereza Sputova ,Adam Salles ,Jeffrey Kang ,Dongliang Zhang ,Steven R Hays ,Jasleen Kukreja ,Jonathan P Singer ,Lewis L Lanier ,Mark R Looney ,John R Greenland ,Daniel R Calabrese

Immune checkpoints HLA-E:CD94-NKG2A and HLA-C:KIR2DL1 complementarily shield circulating tumor cells from NK-mediated immune surveillance

免疫检查点HLA-E:CD94-NKG2A和HLA-C:KIR2DL1互补地保护循环肿瘤细胞免受NK细胞介导的免疫监视。

Liu, Xiaowei; Zuo, Fengli; Song, Jinen; Tang, Leyi; Wang, Xueyan; Liu, Xinyu; Zhang, Hao; Yang, Zhankun; Jing, Jing; Ma, Xuelei; Shi, Hubing